New blood test could predict arthritis risk early

Testing for antibodies that target citrullinated tenascin-C (cTNC) could diagnose rheumatoid arthritis in around 50 percent of cases, including some cases not identified by current best tests. It also has a very low rate of false positives — 98 percent accurate at ruling out rheumatoid arthritis.
Visit the Source Site

Powered by WPeMatico